Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque ...

Arthritis is often associated with older adults, but children can develop it, too. Known as juvenile arthritis, this group of conditions can affect a child’s joints, immune system, and overall health.

Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.